Description
This product combines two distinct research peptides in a single vial: CJC-1295, a growth hormone-releasing hormone (GHRH) analog, and Ipamorelin, a selective growth hormone secretagogue.
This vial uses CJC-1295 without DAC (also known as Mod GRF 1-29), the unmodified 29-amino-acid GHRH(1-29) analog. Sequence corresponds to GRF(1-29)-NH2; molecular formula C152H252N44O42; molecular weight approximately 3367.9 g/mol. Ipamorelin is a pentapeptide with sequence Aib-His-D-2-Naphthylalanine-D-Phe-Lys-NH2, molecular formula C38H49N9O5, molecular weight 711.86 g/mol, CAS 170851-70-4.
Research on this combination examines complementary signaling at the GHRH receptor and the growth hormone secretagogue receptor (GHS-R1a), studying their combined influence on pulsatile signaling pathways in cell-based and animal models.
Supplied as a lyophilized powder blend for reconstitution, each batch is analyzed by HPLC to confirm purity and identity.
For laboratory research use only. Not for human or veterinary use, and not intended for diagnostic or therapeutic application.
